Network Medicine for Alzheimer's Disease and Traditional Chinese Medicine

Molecules. 2018 May 11;23(5):1143. doi: 10.3390/molecules23051143.

Abstract

Alzheimer’s Disease (AD) is a neurodegenerative condition that currently has no known cure. The principles of the expanding field of network medicine (NM) have recently been applied to AD research. The main principle of NM proposes that diseases are much more complicated than one mutation in one gene, and incorporate different genes, connections between genes, and pathways that may include multiple diseases to create full scale disease networks. AD research findings as a result of the application of NM principles have suggested that functional network connectivity, myelination, myeloid cells, and genes and pathways may play an integral role in AD progression, and may be integral to the search for a cure. Different aspects of the AD pathology could be potential targets for drug therapy to slow down or stop the disease from advancing, but more research is needed to reach definitive conclusions. Additionally, the holistic approaches of network pharmacology in traditional Chinese medicine (TCM) research may be viable options for the AD treatment, and may lead to an effective cure for AD in the future.

Keywords: Alzheimer’s disease; inflammation; network and system pharmacology; network medicine; traditional Chinese medicine.

Publication types

  • Review

MeSH terms

  • Alzheimer Disease / diagnosis
  • Alzheimer Disease / drug therapy*
  • Alzheimer Disease / etiology
  • Alzheimer Disease / metabolism
  • Biomarkers
  • Drugs, Chinese Herbal / pharmacology
  • Drugs, Chinese Herbal / therapeutic use*
  • Gene Expression Regulation
  • Humans
  • Medicine, Chinese Traditional*
  • Myelin Sheath / metabolism
  • Myeloid Cells / metabolism
  • Signal Transduction

Substances

  • Biomarkers
  • Drugs, Chinese Herbal